Pernix Therapeutics (PTX) Stock: Gains On Buyout Hopes

Pernix Therapeutics Holdings (NASDAQ: PTX) is having a relatively strong start to the trading session in the pre-market hours today, and for good reason. Notes from Nobby Paul were released today, suggesting that a sale of the company is either under way or likely to take place very soon. Of course, this led to excitement … Read more

BioTech Stocks News | ZGNX | CYTX | ACAD | MNKD | GILD

Zogenix (ZGNX) Produces A Loss For Q4 And Sells Zohydro Zogenix (ZGNX) recently announced that in Q4, the company lost more than $20 million. Also Zogenix (ZGNX) announced that it would be selling its Zohydro ER business to Pernix Therapeutics (PTX). The sale price on the business is $100 million, with an added $283.5 million … Read more